News & Updates

Show Multimedia Only

EFS benefit greater with perioperative vs neoadjuvant-only nivolumab in resectable NSCLC

12 Nov 2024 by

Including adjuvant nivolumab as part of a perioperative regimen for resectable NSCLC further improves the EFS benefit vs including nivolumab in a neoadjuvant-only setting, as suggested by a patient-level data analysis of CheckMate 77T and CheckMate 816 investigating each modality separately

EFS benefit greater with perioperative vs neoadjuvant-only nivolumab in resectable NSCLC

12 Nov 2024

New-gen robotic bronchoscopy safe, effective for peripheral pulmonary lesions

10 Nov 2024 by

A second-generation robotic electromagnetic navigation (EMN) bronchoscopic platform combined with integrated digital tomosynthesis (DT) demonstrates acceptable safety and high diagnostic yield for small peripheral lung nodules, results of the first-in-human study have shown.

New-gen robotic bronchoscopy safe, effective for peripheral pulmonary lesions

10 Nov 2024

Aumolertinib ups PFS in EGFR-mutated NSCLC

08 Nov 2024 by

Treatment with aumolertinib significantly prolonged progression-free survival (PFS) compared with placebo in patients with unresectable stage III EGFR-mutated non-small cell lung cancer (NSCLC) who did not experience disease progression following chemoradiotherapy (CRT), according to a preplanned interim analysis of the phase III POLESTAR trial presented at WCLC 2024.

Aumolertinib ups PFS in EGFR-mutated NSCLC

08 Nov 2024

Original New Drug Application Approvals by US FDA (16-31 October 2024)

07 Nov 2024

New drug applications approved by US FDA as of 16-31 October 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-31 October 2024)

07 Nov 2024

Pneumococcal colonization rate lower in children with persistent asthma

05 Nov 2024 by

Children with persistent asthma are less likely to be colonized with S. pneumoniae than those without asthma when seeking care for respiratory symptoms, reports a study.

Pneumococcal colonization rate lower in children with persistent asthma

05 Nov 2024

RSV may worsen clinical outcomes in HF patients

01 Nov 2024 by

A retrospective analysis presented at HSFA ASM 2024 shows that respiratory syncytial virus (RSV) infection in individuals with heart failure (HF) is associated with greater adverse clinical outcomes.

RSV may worsen clinical outcomes in HF patients

01 Nov 2024

Extreme rainfall puts people’s lives at risk

29 Oct 2024 by

Intense rainfall appears to contribute to a higher risk of death from all causes and cardiovascular or respiratory causes, suggests a study. This association varies with local climate and urban infrastructure.

Extreme rainfall puts people’s lives at risk

29 Oct 2024

DUETS better than Light's criteria for pleural effusion

25 Oct 2024

Use of the Diaphragmatic nodularity, Unilateral, Echogenicity, pleural Thickening and Septations (DUETS) score can accurately separate exudates from transudates in patients with pleural effusion (PE), reports a recent study.

DUETS better than Light's criteria for pleural effusion

25 Oct 2024

Mediterranean diet protective against COVID-19?

24 Oct 2024 by

A higher adherence to the Mediterranean diet (MedDiet) appears to reduce the odds of developing COVID-19, a systematic review suggests.

Mediterranean diet protective against COVID-19?

24 Oct 2024

Real-world study favours ritonavir-based regimens for hospitalized COVID-19 patients

21 Oct 2024 by

In a real-world analysis evaluating four oral antiviral agents for the treatment of COVID-19, two ritonavir-based regimens fared better than molnupiravir and azvudine in reducing hospital stay among patients hospitalized for mild or moderate disease.

Real-world study favours ritonavir-based regimens for hospitalized COVID-19 patients

21 Oct 2024

News & Updates

Filter by Specialty:

Specialty:

EFS benefit greater with perioperative vs neoadjuvant-only nivolumab in resectable NSCLC

EFS benefit greater with perioperative vs neoadjuvant-only nivolumab in resectable NSCLC

New-gen robotic bronchoscopy safe, effective for peripheral pulmonary lesions

New-gen robotic bronchoscopy safe, effective for peripheral pulmonary lesions

Aumolertinib ups PFS in EGFR-mutated NSCLC

Aumolertinib ups PFS in EGFR-mutated NSCLC

Original New Drug Application Approvals by US FDA (16-31 October 2024)

Original New Drug Application Approvals by US FDA (16-31 October 2024)

Pneumococcal colonization rate lower in children with persistent asthma

Pneumococcal colonization rate lower in children with persistent asthma

RSV may worsen clinical outcomes in HF patients

RSV may worsen clinical outcomes in HF patients

Extreme rainfall puts people’s lives at risk

Extreme rainfall puts people’s lives at risk

DUETS better than Light's criteria for pleural effusion

DUETS better than Light's criteria for pleural effusion

Mediterranean diet protective against COVID-19?

Mediterranean diet protective against COVID-19?

Real-world study favours ritonavir-based regimens for hospitalized COVID-19 patients

Real-world study favours ritonavir-based regimens for hospitalized COVID-19 patients